Nicholson Nur (CIK 1827317) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (116,338 shares), Buy APLS (22,610 shares), Sell APLS (22,610 shares), Buy APLS (45,220 shares), Sell APLS (45,220 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 116,338 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Buy | 22,610 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 22,610 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Buy | 45,220 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 45,220 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Buy | 24,284 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 24,284 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Buy | 41,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 41,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 5,645 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 9,754 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 27,320 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 45,220 | $0 |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Buy | 45,220 | $0 |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 7,725 | $168,173 |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 2,203 | $43,597 |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 2,618 | $58,093 |
| 2025-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 825 | $24,354 |
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 3,948 | $120,138 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Sell | 2,145 | $64,264 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Technical Officer | Buy | 36,426 | $0 |
Source: SEC Form 4 filings · as of 2026-05-14